Home/Filings/4/0001225208-24-002856
4//SEC Filing

Szyman Catherine M. 4

Accession 0001225208-24-002856

CIK 0001099800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 6:51 PM ET

Size

5.2 KB

Accession

0001225208-24-002856

Insider Transaction Report

Form 4
Period: 2024-02-22
Szyman Catherine M
CVP, Critical Care & Vascular
Transactions
  • Award

    Common Stock

    2024-02-22+8,56043,373.571 total
Footnotes (1)
  • [F1]These restricted stock units were granted on February 22, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0001438538

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 6:51 PM ET
Size
5.2 KB